Stock PHARMA PHARMANIAGA
Add to a list
To use this feature you must be a member
Log inSign up

Company Pharmaniaga

Equities

PHARMA

MYL7081OO002

Pharmaceuticals

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
0.355 MYR +10.94% Intraday chart for Pharmaniaga +14.52% -7.79%
Apr. 19 China's drugmakers can't sell mRNA shots but haven't quit yet RE
Mar. 27 Pharmaniaga Berhad Appoints Tuan Drs. Imam Fathorrahman as Independent and Non Executive Member of Audit Committee CI

Business Summary

Pharmaniaga Berhad is an investment holding company. The Company is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company operates through three segments: Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution is engaged in the distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products in Malaysia. Indonesia segment is engaged in the manufacturing and distribution of pharmaceutical and medical products in Indonesia. The Company’s subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.

Number of employees: 3,476

Sales per Business

MYR in Million2022Weight2023Weight Delta
Logistics and Distribution
69.3 %
2,515 71.6 % 2,359 69.3 % -6.20%
Indonesia
30.6 %
983 28.0 % 1,040 30.6 % +5.78%
Manufacturing
0.2 %
13 0.4 % 6 0.2 % -56.40%

Sales per region

MYR in Million2022Weight2023Weight Delta
Malaysia
69.3 %
2,519 71.8 % 2,358 69.3 % -6.40%
Indonesia
30.6 %
984 28.0 % 1,040 30.6 % +5.74%
Other Countries
0.2 %
8 0.2 % 6 0.2 % -18.92%

Managers

Managers TitleAgeSince
Norai'ni binti Mohamed Ali DFI
 Director of Finance/CFO 57 01-04-30
Mohd Saharuddin Othman CTO
 Chief Tech/Sci/R&D Officer 52 22-12-31
Abdul Badarulhisam CTO
 Chief Tech/Sci/R&D Officer 56 22-12-31
idham ismail CIO
 Chief Investment Officer 50 22-07-17
Zulkifli bin Jafar BRD
 Director/Board Member 52 20-08-02
Norhana Nawawi Suri LAW
 General Counsel 53 21-11-30
Raja Badli Abdullah PRN
 Corporate Officer/Principal 59 20-10-15
Wan Intan Idura Wan Ismail SEC
 Corporate Secretary 44 09-12-31
Syaruzaimi Yusof SEC
 Corporate Secretary - 19-11-18

Members of the board

Members of the board TitleAgeSince
Izaddeen bin Daud CHM
 Chairman 55 22-11-29
Zulkifli bin Jafar BRD
 Director/Board Member 52 20-08-02
Sarah Azreen binti Abdul Samat BRD
 Director/Board Member 49 -
Ahmad Shahredzuan Mohamed Shariff BRD
 Director/Board Member 41 -
Mohammad Ashraf Md Radzi BRD
 Director/Board Member 45 23-08-09
Abdul Razak Ahmad BRD
 Director/Board Member 53 20-11-19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,441,229,526 601,895,575 ( 41.76 %) 0 41.76 %

Shareholders

NameEquities%Valuation
BOUSTEAD HOLDINGS
47.12 %
679,152,075 47.12 % 48 M RM
Lembaga Tabung Angkatan Tentera
7.832 %
112,882,820 7.832 % 8 M RM
Dasar Technologies Sdn. Bhd.
0.6765 %
9,750,000 0.6765 % 694 590 RM
U Sing Lew
0.5745 %
8,280,000 0.5745 % 589 867 RM
Lodin bin Wok Kamaruddin
0.4232 %
6,100,000 0.4232 % 434 564 RM
Siew Yoon Yong
0.2815 %
4,056,820 0.2815 % 289 008 RM
Public Gold Marketing Sdn. Bhd.
0.2706 %
3,900,000 0.2706 % 277 836 RM
Dassan Solomon Deva
0.2499 %
3,601,200 0.2499 % 256 549 RM
Tabung Amanah Melaka Lembaga
0.2428 %
3,500,000 0.2428 % 249 340 RM
Seng Kian Poh
0.2428 %
3,499,000 0.2428 % 249 269 RM

Company contact information

Pharmaniaga Bhd.

No. 7, Lorong Keluli 1B Kawasan Perindustrian

40000, Shah Alam

+

http://www.pharmaniaga.com
address Pharmaniaga(PHARMA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sales per region

Ratings for Pharmaniaga

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.355 MYR
Average target price
0.31 MYR
Spread / Average Target
-12.68%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
PHARMANIAGA Stock Pharmaniaga
-7.79% 98.27M
MCKESSON CORPORATION Stock McKesson Corporation
+21.27% 72.45B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-4.24% 23.46B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+4.89% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.11% 8.35B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-23.73% 7.88B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+13.92% 5.21B
EBOS GROUP LIMITED Stock EBOS Group Limited
-0.59% 4.11B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+7.85% 4.09B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+20.65% 3.6B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. PHARMA Stock
  4. Company Pharmaniaga